[Interpretation of IASLC/ATS/ERS international multidisciplinary classification of lung neoplasms].
作者信息
Lin Dongmei
机构信息
Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2013 Jun;16(6):277-81. doi: 10.3779/j.issn.1009-3419.2013.06.01.
Abstract
摘要
相似文献
1
[Interpretation of IASLC/ATS/ERS international multidisciplinary classification of lung neoplasms].[国际肺癌研究协会（IASLC）/美国胸科学会（ATS）/欧洲呼吸学会（ERS）肺癌国际多学科分类解读]
Zhongguo Fei Ai Za Zhi. 2013 Jun;16(6):277-81. doi: 10.3779/j.issn.1009-3419.2013.06.01.
2
[Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].[关于国际肺癌研究协会、美国胸科学会和欧洲呼吸学会（IASLC/ATS/ERS）肺腺癌国际多学科分类（2011年）的评论]
Zhonghua Bing Li Xue Za Zhi. 2011 Dec;40(12):793-6.
3
Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.采用国际肺癌研究协会/美国胸科学会/欧洲呼吸学会（IASLC/ATS/ERS）提出的肺腺癌分类方法对肺腺癌进行细胞学亚型分类。
Cancer Cytopathol. 2013 Nov;121(11):629-37. doi: 10.1002/cncy.21314. Epub 2013 Aug 13.
4
Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会新分类在ⅠB期肺腺癌中的预后价值
Eur J Surg Oncol. 2015 Oct;41(10):1430-6. doi: 10.1016/j.ejso.2015.06.004. Epub 2015 Jun 23.
5
[The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].[国际肺癌研究协会（IASLC）/美国胸科学会（ATS）/欧洲呼吸学会（ERS）的肺腺癌国际多学科分类及临床实践中的问题]
Zhongguo Fei Ai Za Zhi. 2013 Jul;16(7):333-8. doi: 10.3779/j.issn.1009-3419.2013.07.01.
6
Subsolid pulmonary nodules: CT-pathologic correlation using the 2011 IASLC/ATS/ERS classification.亚实性肺结节：使用2011年国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类的CT-病理对照
Clin Imaging. 2015 May-Jun;39(3):344-51. doi: 10.1016/j.clinimag.2014.12.009. Epub 2014 Dec 20.
7
8
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.IASLC/ATS/ERS 新分类定义的肿瘤侵袭性对病理分期为 IA 期肺腺癌具有预后意义，并可通过影像学参数预测。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13.
9
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.新型组织学国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类系统是一种与分期无关的生存预测指标。
J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5.
10
Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.从国际肺癌研究协会/美国胸科学会/欧洲呼吸学会（IASLC/ATS/ERS）分类中的近纯亚型肺腺癌中提取放射组学值。
Lung Cancer. 2018 May;119:56-63. doi: 10.1016/j.lungcan.2018.03.004. Epub 2018 Mar 7.
本文引用的文献
1
The molecular pathogenesis and management of bronchial carcinoids.支气管类癌的分子发病机制与治疗管理。
Expert Opin Ther Targets. 2011 Apr;15(4):457-91. doi: 10.1517/14728222.2011.555403. Epub 2011 Jan 29.
2
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.肺腺癌 IASLC/ATS/ERS 分类的影响：基于 514 例 I 期病例分析的预后亚组和对进一步修订分期的影响。
Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.
3
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
4
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.肺低级别和中级别神经内分泌癌（典型和不典型类癌肿瘤）的组织学特征。
Lung Cancer. 2011 Jan;71(1):34-41. doi: 10.1016/j.lungcan.2010.04.007. Epub 2010 May 11.
5
Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator.直径 2 厘米或以下的小肺腺癌的组织学评分：可靠的预后指标。
J Thorac Oncol. 2010 Mar;5(3):333-9. doi: 10.1097/JTO.0b013e3181c8cb95.
6
Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.在活检和细胞学标本中使用黏蛋白染色、TTF-1、细胞角蛋白 5/6 和 P63 以及 EGFR 突变分析的面板，对非小细胞肺癌的诊断和 EGFR 状态进行精细化处理。
J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.
7
Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.浸润大小是肺腺癌生存的独立预测因素。
Am J Surg Pathol. 2009 Mar;33(3):462-9. doi: 10.1097/PAS.0b013e318190157c.
8
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.KRAS基因多态性与伴有非典型腺瘤样增生的肺腺癌风险的关联。
Carcinogenesis. 2008 May;29(5):957-63. doi: 10.1093/carcin/bgn048. Epub 2008 Feb 24.
9
Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.微乳头型肺腺癌：一种具有预后意义的独特组织学亚型。病例系列
Hum Pathol. 2008 Mar;39(3):324-30. doi: 10.1016/j.humpath.2007.05.029.
10
Zotero 插件